Latest News for EKTAY
Anteris Technologies Global (NASDAQ: AVR - Get Free Report) and Elekta (OTCMKTS:EKTAY - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership. Volatility and Risk Anteris Technologies Global has a
Elekta AB (publ) (EKTAY) Shareholder/Analyst Call Transcript
EKTAY jumps after FDA clears Evo CT-Linac, opening U.S. access to AI-driven CT imaging that boosts precision and efficiency in radiation therapy.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for EKTAY.
Senate Trading
No Senate trades found for EKTAY.
U.S. House Trading
No House trades found for EKTAY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.